Browse > Article

The Local Effect after Surgery in Non-small Cell Lung Cancer  

Sa, Young-Jo (Department of Thoracic and Cardiovascular Surgery, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Jeon, Hyun-Woo (Department of Thoracic and Cardiovascular Surgery, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Lee, Sun-Hee (Department of Thoracic and Cardiovascular Surgery, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Wang, Young-Pil (Department of Thoracic and Cardiovascular Surgery, Kangnam St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Park, Jae-Kil (Department of Thoracic and Cardiovascular Surgery, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
Publication Information
Journal of Chest Surgery / v.40, no.5, 2007 , pp. 356-361 More about this Journal
Abstract
Background: Recent progress in the surgical therapy for lung cancer is one of the best examples of the successful evolution of clinical medicine. We reviewed our experience to evaluate the surgical outcomes in patients with non-small cell lung cancer. Material and Method: We reviewed clinical records of 432 consecutive patients with proven non-small cell lung cancer who underwent complete removal of the primary tumor together with hilar and mediastinal lymph nodes from 1995 to 2005. The clinical characteristics, surgical methods, and recurrence patterns were analyzed. Result: Lobectomy was the most common procedure (66.7%) performed and sleeve lobectomy was the least (5.6%). In 179 patients (42.6%) the recurrence was noted and the regional recurrence (67 cases, 16.0%) was less than systemic recurrence (112 cases, 26.7%). The main sites of regional recurrence were hilum (25 cases, 37.3%) and ipsilateral mediastinum (54/432 cases, 25.4%). The hospital mortality rate was 2.8% (12/432 cases) and resection-morbidity rate was 12.5% (54/432 cases). Conclusion: The low recurrence rate, especially regional recurrence rate indicated that our surgical procedures with preoperative measures were considered useful and effective.
Keywords
Lung neoplasms; Lung surgery; Recurrence;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Park IK, Kim DJ, Chung KY, Kim KD, Joo HC. Risk factors for recurrence in completely resected pT1/2N1 nonsmall cell lung cancer. Korean J Thorac Cardiovasc Surg 2005;38:421-7   과학기술학회마을
2 Mitsudomi T, Nishioka K, Maruyama R, et al. Kinetic analysis of recurrence and survival after potentially curative resection of nonsmall cell lung cancer. J Surg Oncol 1996; 63:159-65   DOI   ScienceOn
3 Izbicki JR, Knoefel WT, Passlick B, et al. Risk analysis and long term survival in patients undergoing extended resection of locally advanced lung cancer. J Thorac Cardiovasc Surg 1995;110:386-95   DOI   ScienceOn
4 Cahan WG. Radical lobectomy. J Thorac Cardiovasc Surg 1960;39:555-72   PUBMED
5 Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segment to the mediastinal nodes. J Thorac Cardiovasc Surg 1989;97:623-32   PUBMED
6 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9   PUBMED
7 Grunenwald DH. Surgery for advanced stage lung cancer. Semin Surg Oncol 2000;18:137-42   DOI   PUBMED   ScienceOn
8 Grunenwald DH, Le Chevalier T, Arriagada R. et al. Results of surgical resection in stage IIIB non-small cell lung cancer (NSCLC) after concomittent induction chemo-radiotherapy [Abstract]. Lung Cancer 1997;18(Suppl):73, A280
9 Thomas M, Rube C, Semik M, et al. Impact of preoperative bimodality induction including twice daily radiation on tumor regression and survival in stage III non-small cell lung cancer. J Clin Oncol 1999;17:1185-93   DOI   PUBMED
10 Korean Association for the Study of Lung Cancer. Guidelines for the Management of Lung Cancer - Non-small cell lung cancer. http//www.lungca.or.kr/tmp/20061212.pdf. Accessed December 12, 2006
11 Yokoi K, Matsuguma H, Anraku M. Extrapleural pneumonectomy for lung cancer with carcinomatous pleuritis. J Thorac Cardiovasc Surg 2002;123:184-5   DOI   ScienceOn
12 Ponn RB, LoCicero J 3rd, Daly BDT. Surgical treatment of non-small cell lung cancer. In: Shields TW, LoCicero J 3rd, Ponn RB, Rusch VW. General thoracic surgery. 6th ed. Philadelphia: Lippincott Williams & Wilkins Co. 2005;1548-87
13 Tsuchiya R, Asamura H, Kondo H, et al. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg 1994;57:960-5   DOI   PUBMED   ScienceOn
14 Keller SM, Adak S, Wagner H, Johnson DH. Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa nonsmall cell lung cancer. Eastern cooperative oncology group. Ann Thorac Surg 2000;70:358-65   DOI   PUBMED   ScienceOn
15 Hata E, Miyamoto H, Tanaka M, Sakao Y, Harada R. Superradical operation for lung cancer: bilateral mediastinal dissection (BMD) with or without cervical dissection (CD). Lung Cancer 1994;11(Suppl 2):41-2
16 Albain KS, Rusch VW, Crowly JJ, et al. Concurrent cisplatin/Etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell cancer: mature results of Southwest Oncology Group phase II study 88-05. J Clin Oncol 1995;13:1880-92   PUBMED
17 Paulson DL, Urschel Jr HC, McNamara JJ, Shaw RR. Bronchoplastic procedure for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1970;59:38-48   PUBMED
18 Hata E, Miyamoto H, Hayakawa K, Hayashida R. Rationale for extended lymphadenectomy for lung cancer. Theoretical Surg 1990;5:19-25
19 Roviaro GC, Varoli F, Rebuffat C, et al. Videothoracoscopic staging and treatment of lung cancer. Ann Thorac Surg 1995;59:971-4   DOI   ScienceOn
20 Dartevelle PG. Extended operation for the treatment of lung cancer. Ann Thorac Surg 1997;63:12-9   DOI   PUBMED   ScienceOn